1. Home
  2. FCN vs CYTK Comparison

FCN vs CYTK Comparison

Compare FCN & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FCN
  • CYTK
  • Stock Information
  • Founded
  • FCN 1982
  • CYTK 1997
  • Country
  • FCN United States
  • CYTK United States
  • Employees
  • FCN N/A
  • CYTK N/A
  • Industry
  • FCN Professional Services
  • CYTK Biotechnology: Pharmaceutical Preparations
  • Sector
  • FCN Consumer Discretionary
  • CYTK Health Care
  • Exchange
  • FCN Nasdaq
  • CYTK Nasdaq
  • Market Cap
  • FCN 5.5B
  • CYTK 5.6B
  • IPO Year
  • FCN 1996
  • CYTK 2004
  • Fundamental
  • Price
  • FCN $158.86
  • CYTK $32.43
  • Analyst Decision
  • FCN Hold
  • CYTK Buy
  • Analyst Count
  • FCN 2
  • CYTK 14
  • Target Price
  • FCN $175.50
  • CYTK $70.92
  • AVG Volume (30 Days)
  • FCN 382.4K
  • CYTK 1.3M
  • Earning Date
  • FCN 07-24-2025
  • CYTK 08-07-2025
  • Dividend Yield
  • FCN N/A
  • CYTK N/A
  • EPS Growth
  • FCN N/A
  • CYTK N/A
  • EPS
  • FCN 7.32
  • CYTK N/A
  • Revenue
  • FCN $3,668,381,000.00
  • CYTK $19,218,000.00
  • Revenue This Year
  • FCN $0.23
  • CYTK $18.02
  • Revenue Next Year
  • FCN $6.96
  • CYTK $737.32
  • P/E Ratio
  • FCN $22.05
  • CYTK N/A
  • Revenue Growth
  • FCN 1.59
  • CYTK 412.21
  • 52 Week Low
  • FCN $151.75
  • CYTK $29.31
  • 52 Week High
  • FCN $243.60
  • CYTK $61.38
  • Technical
  • Relative Strength Index (RSI)
  • FCN 39.68
  • CYTK 46.32
  • Support Level
  • FCN $158.27
  • CYTK $32.02
  • Resistance Level
  • FCN $163.43
  • CYTK $34.72
  • Average True Range (ATR)
  • FCN 2.96
  • CYTK 1.30
  • MACD
  • FCN -0.21
  • CYTK 0.26
  • Stochastic Oscillator
  • FCN 23.07
  • CYTK 45.08

About FCN FTI Consulting Inc.

FTI Consulting Inc is a firm that generates its sales by providing professional business advisory services to customers. The company operates through five segments, namely corporate finance, forensic and litigation consulting, economic consulting, technology, and strategic communications. The company generates the majority of its revenue from the Corporate finance segment. Customers of the company come from a wide array of sectors, including construction, energy and power, environmental, financial institutions, healthcare and life science, insurance, real estate and infrastructure, retail and consumer products, telecom, media, and technology. The majority of the company's revenue is derived from serving customers in the United States.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: